Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions. [electronic resource]
Producer: 20040519Description: 10710-9 p. digitalISSN:- 0021-9258
- 1-Methyl-4-phenylpyridinium -- pharmacology
- Acetylcysteine -- analogs & derivatives
- Animals
- Brain -- metabolism
- Caspase 3
- Caspase Inhibitors
- Caspases -- metabolism
- Cysteine Endopeptidases -- metabolism
- Dopamine -- metabolism
- Dopamine Agents -- metabolism
- Dose-Response Relationship, Drug
- Enzyme Inhibitors -- pharmacology
- Herbicides -- pharmacology
- Immunoblotting
- Immunohistochemistry
- Ions
- L-Lactate Dehydrogenase -- metabolism
- Leupeptins -- pharmacology
- MAP Kinase Signaling System
- Male
- Mitochondria -- metabolism
- Mitogen-Activated Protein Kinase 1 -- metabolism
- Mitogen-Activated Protein Kinase 3
- Mitogen-Activated Protein Kinases -- metabolism
- Multienzyme Complexes -- antagonists & inhibitors
- Nerve Tissue Proteins -- metabolism
- Neurons -- metabolism
- Phosphorylation
- Proteasome Endopeptidase Complex
- Rats
- Rats, Wistar
- Rotenone -- metabolism
- Synucleins
- Time Factors
- Ubiquitin -- metabolism
- alpha-Synuclein
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.